靶点- |
作用机制- |
|
|
|
非在研适应症- |
最高研发阶段临床1/2期 |
首次获批国家/地区- |
首次获批日期- |
/ Not yet recruiting临床1/2期IIT Standard Optimization of Autologous Stem Cells by Intranasal and Intravenous Administration to Treat Parkinson's Disease and Atypical Parkinsonism
The purpose of this study is to measure outcomes using intranasal and intravenous autologous bone marrow mesenchymal stem cells (BM-MSCs) for Parkinson Disease (PD) and Parkinson's Plus (PPS) patients.
100 项与 Apeiron Research Center 相关的临床结果
0 项与 Apeiron Research Center 相关的专利(医药)
100 项与 Apeiron Research Center 相关的药物交易
100 项与 Apeiron Research Center 相关的转化医学